Key opportunities in the targeted drug delivery market include advances in precision medicine, next-gen carrier tech, strategic partnerships, resilient supply chains, and patient-centric design.

The nanomedicine market is largely propelled by the increasing demand for precise and more effective treatments, especially for cancer, cardiovascular conditions, and other chronic diseases, where ...

Announcing a new article publication for BIO Integration journal. Pulmonary fibrosis (PF) is a progressive interstitial lung disease characterized by excessive extracellular matrix deposition and ...

Opportunities include personalized therapies, digital health integration, specialized formulations, smart delivery devices, and collaboration for innovation cycle advancement. Drug Delivery Systems ...

Neuroinflammation drives the progression of neurodegenerative disorders like Alzheimer's, Parkinson's, and multiple sclerosis ...

Executive SummaryThe global pharmaceutical drug delivery sector operates as a central pillar within the broader life sciences industry. As treatment protocols shift from conventional dosing toward ...

Nanoparticles enhance drug solubility, stability, and bioavailability, improving therapeutic outcomes for GI conditions like IBD through targeted delivery mechanisms. Hydrogel-based systems offer ...

Key opportunities in the drug delivery devices market include expanding digital health partnerships for innovative injectable and connected solutions, addressing chronic conditions like asthma and ...

VANCOUVER, BC, BC / ACCESS Newswire / October 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing ...

Fabricated with a gel side for carrying drugs and a magnetic side for steering, these microrobots can navigate complex biological environments like intestines. Microrobots formed in droplets could ...